The treatment of immune thrombocytopenia (ITP) can be challenging. The immature platelet count (IPF#) can help, making it easier to monitor the efficacy of the different treatment mechanisms and assessing bleeding risks. This white paper explains how.
The intended objective of this newsletter is to highlight the importance of early detection of chronic kidney disease (CKD). The diagnosis of CKD often require the input of many disciplines along side that of the primary health care giver. It is common for patients with CKD to also have other chronic conditions, including but not restricted to hypertension, diabetes and cardiovascular disease.
Malaria is a detectable, preventable, and curable disease, but the burden on global health is still very high. This SEED article discusses a broad range of aspects, from the latest figures from the World Health Organisation and the Plasmodium life cycle to the limitations of stablished diagnostic tests, and how new technologies, such as the Sysmex XN-31 analyser, can enlighten the way towards malaria elimination.
Abnormal RBC results generate extra workload for laboratories and require careful interpretation to guide treatment options. This white paper describes common RBC diseases, both acquired and hereditary, that are frequently encountered in a routine laboratory, and presents how intelligent interpretation of blood counts and algorithms can help identifying these conditions. Subsequent confirmatory tests lead to improved turn-around times.
During HSCT patients suffer from many critical conditions such as thrombocytopenia or infections, as well as it is necessary to closely monitor the engraftment. This white paper explains how a Sysmex haematology analyser can answer your clinical demands.
A deeper insight about an activation of the immune response of patients can be acquired from newly available diagnostic parameters that support differentiation between inflammation and infection, different pathogenic causes of infection (viral versus bacterial) and different types of immune response: early innate, cellular or humoral immune response.